Open access
Aug 2026
Anoikis associated long noncoding RNA signature predicts prognosis and small molecule drug response in glioma across multiple databases
The established eight-ARlncRNA signature serves as a robust prognostic tool, effectively predicting patient survival and mirroring the heterogeneity of the tumor immune landscape, and offers potential guidance for personalizing therapeutic strategies in glioma.
Yuting Ouyang, Rui Han, An-Qi Song et al.
· Discover Oncology · 0 citations